What is the management and treatment of annular rupture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Annular Rupture: Definition and Management

What is Annular Rupture?

Annular rupture is a rare but devastating complication of transcatheter aortic valve replacement (TAVR) involving injury to the aortic root and left ventricular outflow tract, with mortality rates approaching 50% when it occurs. 1

Annular rupture encompasses different procedural-related injuries classified by anatomical location into four main types: supra-annular, intra-annular, subannular, and combined rupture 2. This complication typically manifests as sudden cardiac tamponade with hemodynamic collapse during or immediately after valve deployment 1, 3.

Risk Factors for Annular Rupture

Patient-Related Risk Factors

  • Female sex 1
  • Smaller annular size (particularly <21 mm) 1
  • Small sinotubular junction 1
  • Prior radiation therapy 1
  • Porcelain aorta 1

Anatomic Risk Factors

  • Bulky and dense calcification, particularly moderate-to-severe sub-annular calcification 1
  • Protruding landing zone calcification below the non-coronary cusp is most closely associated with annular injury 1, 4
  • Depth of calcification within the LVOT, especially calcification extending >1 mm into the lumen 4

Procedural Risk Factors

  • Use of balloon-expandable valves (higher radial force) 1
  • Aggressive balloon predilation 1
  • Significant prosthesis oversizing, particularly when combined with protruding calcification 1, 4

Management Algorithm

Immediate Recognition and Stabilization

The key to survival is immediate recognition through hemodynamic monitoring and echocardiographic surveillance, followed by rapid escalation of therapy based on bleeding severity. 1, 3

Step 1: Identify Hemodynamic Instability

  • Monitor for sudden hypotension during or immediately after valve deployment 3
  • Maintain high index of suspicion in high-risk patients (female, heavy calcification, aggressive oversizing) 1

Step 2: Confirm Diagnosis

  • Perform immediate echocardiography (TEE or TTE) to identify pericardial effusion and tamponade 1, 3
  • Aortic root angiography can confirm contrast extravasation 3

Treatment Approach Based on Severity

Management options range from comfort care in moribund patients to emergent surgical conversion, with the choice depending on bleeding severity, hemodynamic stability, and surgical candidacy. 1

For Smaller, Contained Leaks:

  • Emergent pericardiocentesis to relieve tamponade 1, 3
  • Pericardial drainage with autotransfusion 1
  • Placement of pericardial drain for ongoing evacuation 3
  • Injection of hemostatic agents (e.g., SURGIFLO) into pericardial space 3
  • Repeat aortogram to confirm cessation of extravasation 3
  • Coil embolization at the rupture site has been reported as successful percutaneous alternative 5

For Ongoing Hemorrhage or Hemodynamic Instability:

  • Emergent conversion to open surgical repair with pericardial patching of the defect 1, 3, 6
  • Extracorporeal membrane oxygenation (ECMO) support may be necessary for cardiac arrest or severe hemodynamic compromise 6
  • Delayed chest closure (post-op day 2) may be required for ongoing bleeding 3

For Moribund Patients:

  • Comfort care and sedation when no other viable options exist 1

Prevention Strategies

Prevention through meticulous pre-procedural CT planning and appropriate valve selection is paramount given the high mortality of this complication. 1, 4

Pre-Procedural CT Assessment

  • Mandatory gated cardiac CT with multiphasic reconstruction to identify systolic phase with largest annular dimensions 4
  • Qualitative grading of LVOT calcification as none, mild, moderate, or severe based on depth, morphology, and location 1, 4
  • Document specific location of protruding calcification, especially below the non-coronary cusp 1, 4
  • CT-based area and perimeter measurements are mandatory over 2D echocardiographic measurements alone 4

Valve Selection and Sizing

  • Reduce degree of oversizing in patients with moderate-to-severe subannular calcification, particularly protruding nodules 1, 4
  • Consider self-expandable valves in high-risk anatomy, as they exert lower radial force than balloon-expandable valves 4
  • Avoid aggressive balloon predilation in heavily calcified annuli 1

High-Risk Scenarios Requiring Special Consideration

  • Protruding nodules below the non-coronary cusp carry the highest rupture risk and warrant reduced oversizing or valve platform change 1, 4
  • Female patients with small annuli (<21 mm) and heavy calcification represent the highest-risk cohort 1, 4

Common Pitfalls

  • Undersizing the valve due to reliance on 2D echo measurements leads to paravalvular regurgitation; always use CT-based area/perimeter 4
  • Aggressive oversizing in the presence of protruding LVOT calcification dramatically increases annular rupture risk 4
  • Failing to document the specific location of protruding calcification prevents informed valve selection and risk stratification 4
  • Delayed recognition of tamponade due to inadequate echocardiographic monitoring during and immediately after deployment 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

TAVI in Small Annulus and LVOT Calcification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.